Septerna Inc - SEPN Company Short-Term Debt

Graphic logo of Septerna Inc (SEPN)

Septerna Inc (SEPN) operates as a biotech system where the absence of sales is offset by the value of unique developments, and success depends on FDA verdicts. This chart reflects a current market value of 0.01, illustrating the dynamics of a company seeking partnerships with industry behemoths through the AI-driven creation of small molecules. While compound synthesis is automated, final human trials remain the responsibility of experts.

SEPN (Septerna, Inc.) Company Short-Term Debts history from 10/26/2024 to 10/28/2026

Septerna Pharma - analytical breakdowns and key metrics (SEPN)

- price and consensus price forecast:
Price Chart Septerna|SEPN - Fair Value Consensus
- market capitalization data:
Market Value Septerna Inc|SEPN - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Septerna|SEPN - Book Capitalization|Market Cap to Net Assets Ratio septerna.com|SEPN - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Septerna Inc|SEPN - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Septerna Inc|SEPN - Company Total Debt|Debt to Book Capitalization Ratio Septerna Inc|SEPN - Company Long-Term Liabilities|Company Current Liabilities Septerna
Fundamental company valuation:Septerna - SEPN
Product sample of Septerna Inc

Long-term investing requires strict liquidity control to minimize credit risks. For Septerna Inc (SEPN), which is diversifying its developments in cell receptors, maintaining a capital balance is critically important. The company's current liabilities reflect the repayment dynamics of short-term loans based on daily data. A sharp decline in this metric indicates increasing solvency but may limit working capital. An optimal debt level ensures the stable development of immune and endocrine therapies.

Competitor analysis

Company Short-Term Debt argenx (ARGX)|BNTX: Company Short-Term Loans and Borrowings|ABVX (Abivax) - Company Short-Term Debt|ADMA Corp (ADMA) - Company Current Liabilities|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com (IMVT)|Kiniksa (KNSA) - Company Current Liabilities|Company Short-Term Loans and Borrowings Grifols SA (GRFS)|Company Short-Term Debts ADPT|Celldex Corp - Short-Term Debt Volume|AUPH: Company Short-Term Debt|BCRX: Company Current Liabilities|VERA (Vera Therapeutics) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|PHVS (Pharvaris Corp) - Company Current Liabilities|Company Short-Term Debts ABCL|Company Short-Term Debt Tourmaline Bio, Inc. TRML|Company Short-Term Indebtedness precigen.com (PGEN)|PHAR: Company Short-Term Debts|Nektar Therapeutics Inc - Short-Term Debt|Company Short-Term Debt UPB (Upstream Bio Corp)|ZBIO - Short-Term Debt Volume|Company Short-Term Debts IMNM|GOSS (gossamerbio.com) - Short-Term Debt|Company Short-Term Debt KalVista Pharmaceuticals, Inc. KALV|Current Liabilities Pieris Pharma (PVLA)|Company Current Liabilities Savara Corp|Amount of Current Liabilities Rigel Corp (RIGL)|ANAB: Company Short-Term Debts|astriatx.com - Short-Term Debt|Company Short-Term Debt enGene (ENGN)|RAPT: Company Short-Term Loans and Borrowings|Company Short-Term Debt aerovatetx.com|Aclaris Therapeutics, Inc (ACRS) - Company Short-Term Indebtedness|KYTX (Kyverna Therapeutics) - Company Short-Term Debts|Company Short-Term Debts tizianalifesciences.com (TLSA)|Cabaletta Bio (CABA) - Company Current Liabilities|Company Short-Term Loans and Borrowings Ventyx Biosciences Inc. (VTYX)|Company Short-Term Debts THTX|Avalo Therapeutics Inc - Short-Term Debt Volume|Eledon Pharmaceuticals (ELDN) - Company Short-Term Debt|AGEN - Company Short-Term Indebtedness|CLYM (Climb Bio) - Company Short-Term Debts|ZURA (zurabio.com) - Company Current Liabilities|ATYR: Company Short-Term Debt|Short-Term Debt Volume Adagene Corp|ImageneBio Inc - Company Short-Term Debts|Short-Term Debt STTK (shattucklabs.com)|Equillium (EQ) - Company Short-Term Debt|Connect Biopharma Holdings - Current Liabilities|Immunic Inc (IMUX) - Company Short-Term Debt|ATRA: Company Short-Term Indebtedness|Company Short-Term Debt inflarx.de (IFRX)|x4pharma.com (XFOR) - Current Liabilities|ACET - Company Short-Term Debts|Company Short-Term Loans and Borrowings Celularity Corp|Company Short-Term Debts INMB|Company Short-Term Debts BRNS (Barinthus Biotherapeutics Corp)|Company Short-Term Debt Kezar Life Sciences|sabbiotherapeutics.com - Company Short-Term Loans and Borrowings|AKTX: Company Short-Term Debt|ENLV - Company Current Liabilities|QTTB: Company Short-Term Debts|Company Short-Term Debts GeoVax Corp|EDSA - Company Current Liabilities|Company Short-Term Loans and Borrowings ibioinc.com|CARM (Carisma Therapeutics) - Company Short-Term Debts|Short-Term Debt Volume XTLB (XTL Biopharmaceuticals Ltd)|Bolt Biotherapeutics, Inc. - Company Short-Term Debt|HCW Biologics, Inc. - Company Current Liabilities|APVO: Company Short-Term Debt|aimimmuno.com (AIM) - Company Current Liabilities|ADTX: Company Current Liabilities|GRI (GRI Bio Inc) - Company Short-Term Debts|Company Short-Term Debt XORTX (XRTX)|Company Short-Term Indebtedness Vyome Therapeutics|Revelation Biosciences - Company Short-Term Debts|Short-Term Debt INDP (indaptusrx.com)|Company Short-Term Debt SCNI|Short-Term Debt Volume CalciMedica Inc CALI|AFMD (Affimed Therapeutics) - Company Short-Term Debts|ALLK: Short-Term Debt|Company Short-Term Debt hookipapharma.com (HOOK)|Current Liabilities IGM Biosciences|iTeos Therapeutics, Inc. (ITOS) - Company Current Liabilities|Amount of Current Liabilities Ocean Biomedical Inc|TC BioPharm (Holdings) PLC - Company Short-Term Debts|Short-Term Debt THRD (Third Harmonic Bio Inc)